VC-backed Celladon files for IPO
San Diego-based biopharmaceutical company Celladon Corp. has filed for an IPO. The number of shares to be offered and pricing terms have yet to be decided. J.P. Morgan and Barclays are serving as lead underwriters. Celladon is backed by MPM Capital, LSP Life Sciences Partners, Pfizer Venture Investors, Lundbeckfond Ventures, Novartis Venture Funds, Tekla Capital Management, GBS Venture Partners and Enterprise Partners Venture Capital.
14 October 2013•3 mins read
